I9SA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Verona Pharma PLC

Watchlist Manager

Watchlist

Price: 90.2 EUR 0.67% Market Closed

Market Cap: €7.3B

V	Verona Pharma PLC F:I9SA	UK
P	PSI Software AG XBER:PSAN	DE
M	Moody's Corp DUS:DUT	US
	Aedifica NV F:AOO	BE
	Fox Corp F:FO5	US
T	Trane Technologies PLC XMUN:2IS	IE
C	Canadian Pacific Railway Ltd F:PC8	CA
	Happinet Corp OTC:HAPYF	JP
E	Eva Precision Industrial Holdings Ltd F:GZT	HK
M	Microport Scientific Corp OTC:MCRPF	CN
	Kernel Holding SA F:0KE	UA
B	Bio-Techne Corp SWB:TE1	US
	UL Solutions Inc F:72R	US
S	Safran SA XMUN:SEJ1	FR
S	Schlumberger NV SWB:SCL	US
M	Mckesson Corp XBER:MCK	US

Profitability Summary

Verona Pharma PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

94%

Negative Operating Margin

-25%

Negative 3Y Average Operating Margin

-6 716%

Operating Margin is Increasing

-16 022% > -25%

Negative Net Margin

-37%

Negative 3Y Average Net Margin

-5 535%

Net Margin is Increasing

-13 176% > -37%

Negative Free Cash Flow Margin

-33%

Negative 3Y Average Free Cash Flow Margin

-5 034%

Free Cash Flow Margin is Increasing

-11 122% > -33%

Negative ROE

-36%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-268%

ROIC is Increasing

-280% > -80%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.